This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spidel, J. L.
Right arrow Articles by Wills, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spidel, J. L.
Right arrow Articles by Wills, J. W.

 Previous Article  |  Next Article 

Journal of Virology, February 2007, p. 1288-1296, Vol. 81, No. 3
0022-538X/07/$08.00+0     doi:10.1128/JVI.01551-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Genetic Studies of the ß-Hairpin Loop of Rous Sarcoma Virus Capsid Protein{triangledown}

Jared L. Spidel,{dagger} Carol B. Wilson, Rebecca C. Craven,* and John W. Wills

Department of Microbiology and Immunology, The Pennsylvania State University, College of Medicine, Hershey, Pennsylvania 17033

Received 19 July 2006/ Accepted 31 October 2006


arrow
ABSTRACT
 
The first few residues of the Rous sarcoma virus (RSV) CA protein comprise a structurally dynamic region that forms part of a Gag-Gag interface in immature virus particles. Dissociation of this interaction during maturation allows refolding and formation of a ß-hairpin structure important for assembly of CA monomers into the mature capsid shell. A consensus binding site for the cellular Ubc9 protein was previously identified within this region, suggesting that binding of Ubc9 and subsequent small ubiquitin-like modifier protein 1 (SUMO-1) modification of CA may play a role either in regulating the assembly activity of CA in immature particles or mature cores or in controlling postentry function(s) during the establishment of infection. In the present study, mutations designed to eliminate the consensus binding site were used to dissect the potentially overlapping functions of these residues. The resulting replication defects could not be traced to a failure to form particles of normal composition but, rather, to a deficit in genome replication. Genetic suppressors of two detrimental ß-hairpin mutations improved infectivity without restoring the consensus site or creating a novel one elsewhere. Optimal restoration of infectivity to a Lys-to-Arg mutant required a combination of secondary changes, one on the surface of each domain of CA. Rather than arguing for a critical role of Ubc9 and SUMO in RSV replication, these findings provide strong support for a structural role of the N-terminal residues and a particularly striking example of long-range interactions between regions of CA in achieving a functional core competent for genome replication.


arrow
INTRODUCTION
 
The CA (capsid) protein, the major structural protein of all infectious orthoretroviruses, plays critical roles in both the assembly and postentry phases of the replication cycle. As a domain of the Gag protein, CA contributes to the structural framework of the immature particle (19, 63, 64). Once liberated from Gag by proteolytic processing late in the assembly process, CA condenses to form a protein shell around the genome-protein complex, consisting of viral RNA, tRNA, the nucleocapsid protein (NC), and the reverse transcriptase (RT) and integrase (IN) enzymes. Structural integrity of the CA shell in this mature core appears to be critical for activity of the reverse transcription complex in replicating the viral genome. An extensive genetic analysis of the CA protein of human immunodeficiency virus type 1 (HIV-1) demonstrated a strict correlation between normal capsid morphology and infectivity (59). In the Rous sarcoma virus (RSV), mutations that perturb the integrity of CA and the capsid have potent effects on infectivity due a failure to reverse-transcribe the viral genome (7, 12). Numerous other studies have described CA mutations that cause loss of reverse transcription and infectivity without detectable effects on particle formation (1, 13, 17, 18, 33, 43, 44, 52, 54, 55, 60). These genetic studies suggest that the properly assembled CA plays a critical role during the early stages of the virus infection cycle. This interpretation is consistent with the demonstration that CA protein remains associated with cytosolic core-derived structures of HIV and of murine leukemia virus (MLV) during the process of reverse transcription (4, 14, 15, 36) and with the activity of mammalian cell restriction factors that block retrovirus infection by targeting CA in the incoming core (22, 40, 51, 57). Still, the mechanisms through which CA contributes to early replication events remain unexplained.

The first few amino acids of the CA protein comprise a structural element with an important role in the core maturation processes that yield the properly assembled capsid. The amino terminus of the CA domain exists in an unfolded conformation in the Gag proteins of HIV and RSV and in the latter, at least, forms part of an extended interface between Gag molecules (39, 53). Cleavage of Gag by the viral protease PR to form the amino terminus of mature CA allows refolding of this region into a ß-hairpin structure. In HIV, this refolding is known to be accompanied by structural changes throughout the N-terminal domain (NTD) of CA that appear to facilitate formation of NTD-NTD interactions and maturation of the core (39, 53, 58). Mutations that prevent the hairpin from being anchored to the N-terminal domain of CA have been shown to prevent core formation and infectivity in HIV and MLV (44, 58).

A crystallographic study of the CA NTD from MLV (37) demonstrated that the ß-hairpin and first three {alpha}-helices of CA form the interfaces that hold the NTDs of six CA monomers together in a hexameric ring structure that forms a prominent repeating feature of the capsid outer surface. The six ß-hairpins line the wall of the central cavity of the hexameric ring (37). Neighboring hexamers are linked via dimeric C-terminal domain (CTD)-CTD interactions involving helix 9 that have been well characterized in HIV (31). Cryoelectron microscopy of in vitro assembled HIV CA (31) and analyses of RSV, HIV, and MLV CA proteins assembled on lipid monolayers (2, 20, 35) suggest that all orthoretroviruses use similar principles of protein organization to assemble a functional core. In addition to the well-documented NTD-NTD and CTD-CTD interactions, the presence of an NTD-CTD interface in assembled, mature HIV CA, but not in the immature Gag particles, has been demonstrated by hydrogen-deuterium exchange and protein chemical cross-linking (29, 30). Involvement of the interdomain interface is supported by genetic studies of RSV from our laboratory (5, 29, 30) but has not yet been confirmed by high-resolution methods in any virus.

Intriguingly, a consensus amino acid sequence (IKTE) was identified in the ß-hairpin of the RSV CA protein (50) which could potentially act as a binding site for the cellular regulatory protein Ubc9. The conjugation activity of Ubc9 is known to catalyze the modification of the target protein by covalent attachment of the small ubiquitin-like modifier protein 1, SUMO-1, to a lysine residue in or near the Ubc9-binding site (23, 45). Protein sumoylation is known in numerous systems to be involved in the control of a variety of nuclear events including entry, subnuclear structure formation, and the modulation of transcriptional activity, although the mechanisms of action are not well understood (23, 49). Numerous examples of sumoylation of viral regulatory proteins (23), but only a small number of structural proteins, have been documented. This group includes at least two hantavirus NP proteins (27, 32) and two retroviral CA proteins (61, 65). The CA proteins of Mason-Pfizer monkey virus and MLV have been shown by yeast two-hybrid analysis and in vitro interaction studies to bind Ubc9 (61, 65). Lysine substitution in the Ubc9 binding site in MLV blocked both in vitro sumoylation of CA and the establishment of infection after the step of viral DNA synthesis, suggesting that SUMO modification of CA may be important for an unidentified early step of virus infection near or in the nucleus. Thus, Ubc9 and SUMO-1 represent attractive candidates as regulators of CA function in reverse transcription and/or nuclear events during the establishment of retroviral infections. In RSV the location of the IKTE motif within the ß-hairpin raises a further possibility that SUMO and/or Ubc9 could serve to regulate CA protein folding and/or capsid assembly.

In a previous study, replacement of the lysine residue in the IKTE motif with arginine dramatically reduced RSV infectivity but did not affect particle production, suggesting a possible role for the sumoylation machinery in the maturation and/or early postentry phases of replication (50). To evaluate the significance of the IKTE motif for the viral life cycle and dissect potentially overlapping functions in this region, an examination of the replication defect in the arginine substitution mutant and a more detailed genetic analysis, including isolation of second site suppressors, was undertaken. The findings support the importance of the region in the assembly of a functional core structure but do not identify a critical role for Ubc9 and SUMO-1 in RSV replication.


arrow
MATERIALS AND METHODS
 
Plasmids. CA mutations were created in the Prague C gag gene derived from the proviral vector pATV-8 (26, 48) and cloned into either pJD100, a replication-competent proviral vector which bears the src gene, or pRS.V8.eGFP, in which src is replaced by the enhanced green fluorescent protein (EGFP) gene (8). The K244R substitution was transferred to pJD100 using the two SacII sites in gag. New mutations, T245I, E246A, and E246D, were generated by PCR mutagenesis; the threonine codon ACA was replaced with ATA, and the glutamate GAG was replaced with either GCG (alanine) or GAC (aspartate). The mutant alleles were then transferred into pRS.V8.eGFP using SstI and FseI, thereby replacing the 5' half of gag. R325C, C431R, R325C/C431R, and N343D substitutions were similarly created by changing the arginine codon CGC to TGC (cysteine), the cysteine TGC codon to CGC (arginine), and asparagine AAT to GAT (aspartate). The C431R mutation was transferred into pRS.V8.eGFP or pRS.K244R.eGFP using SdaI in gag and BstXI in pol. R325C and N343D mutations were transferred into various proviral plasmids using SstI and SdaI, replacing the N-terminal half of gag. All clones were confirmed by DNA sequencing.

Budding assays. Assembly and release of virus particles by the wild-type and mutant Gag proteins was analyzed by transfection of QT6 cells (38) with proviral plasmids as described previously (7). Particles released from [35S]methionine-labeled cells were immunoprecipitated with rabbit anti-RSV serum, separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and then quantified by phosphorimage analysis. Budding efficiency was calculated by normalizing the amount of radiolabeled CA released into the medium for the amount of Gag expression measured in a parallel plate of cells; activity of the mutants was expressed relative to the wild type.

Infectivity assays. Virus-spreading assays were performed as previously described (50). Viruses produced by transfection of QT6 cells were normalized for RT activity by an exogenous RT assay (12) and used to infect plates of chicken DF-1 cells (46). Infected (i.e., GFP-expressing) cells were detected at postinfection time points by fluorescence-activated cell sorting. The point at which 50% of cells were GFP positive was evaluated by visual examination of the data. Focus formation assays were performed as previously described (5, 25) using the wild-type and K244R allele in the pJD100 vector to produce particles in QT6 for inoculation into primary turkey embryo fibroblasts.

Microscopy. For subcellular localization of GFP-tagged Gag, QT6 cells on coverslips were transfected with either wild-type (WT) pGag.GFP (8) or its K244R derivative. After 24 h, cells were treated with dimethyl sulfoxide (negative control) or with 10 µg/ml leptomycin B; cells were then fixed with paraformaldehyde and examined using a Leica TCS SP2 AOBS confocal microscope with a helium-argon laser (47). For electron microscopy (EM), stably infected DF-1 cells in 60 mm Permanox dishes (Electron Microscopy Sciences, Ft. Washington, PA) were processed for EM as described previously (12).

Core detergent resistance. To examine core stability, radiolabeled virions from stably infected DF-1 cells were pelleted through sucrose solutions containing either 1% Triton X-100 or no detergent. The CA protein in each of the resulting supernatant and pellet fractions was quantified by immunoprecipitation with anti-RSV serum, SDS-PAGE, and phosphorimage analysis and then expressed as a percentage of the total CA (5).

RT and Env incorporation. Virions from [35S]methionine-labeled DF-1 cells stably infected with WT or K244R virus were collected by ultracentrifugation through a 25% sucrose cushion at 126,000 x g for 40 min at 4°C in a Beckman TLA100.4 rotor. The RT activity in each resulting virus pellet was determined by the exogenous RT assay (12). In parallel, CA proteins were analyzed by radioimmunoprecipitation with anti-RSV serum, SDS-PAGE, and phosphorimage analysis, and a CA:RT ratio was calculated. For Env analysis, unlabeled virions were collected in similar fashion. Env and CA were visualized by Western blot analysis using rabbit anti-TM (transmembrane protein) and rabbit anti-RSV antibodies, respectively. Env and CA bands were quantified by densitometry and data expressed as a ratio.

RNA and DNA isolation. WT and K244R particles from stably infected DF-1 cells were collected for 24 h, passed through a 0.45-µm-pore-size filter, pelleted through 20% sucrose at 20,000 x g for 3 h, resuspended in phosphate-buffered saline, and normalized for their exogenous RT activity (12). RNA was extracted from equal amounts of WT and mutant virions using the QIAmp Viral RNA mini kit (QIAGEN), treated with DNA-free DNase (Ambion), and analyzed by quantitative reverse transcription-PCR (RT-PCR) (see below). For isolation of viral DNA from infected cells, normalized suspensions of WT and mutant particles were added to uninfected DF-1 cells, and low-molecular-weight viral DNA was isolated at 14 h postinfection (7, 24). For preparation of endogenous reverse transcription (ERT) products, equal amounts of the WT and mutant viruses were incubated in standard ERT buffer to activate reverse transcription (7, 41). After 3 h at 42°C, the resulting viral DNA was extracted using a QIAquick PCR purification kit (QIAGEN) and analyzed by quantitative PCR.

Q-PCR. The following primers corresponding to the RSV long terminal repeat (LTR) and the 5' and 3' untranslated regions were designed to amplify various regions of the viral DNA produced by reverse transcription in infected cells: primer A (5'-GCCATTTGACCATTCACCA-3') and primer B (5'-AATGAAGCCTTCTGCTTCATG-3') for minus-strand strong stop DNA; primer C (5'-ATTCCGCATTGCAGAGATATTG-3') and primer B for first-strand transfer; primer A and primer D (5'-GATGGAGACAGGATCGCCAC-3') for second-strand transfer; and primer A and E (5'-CATGTTGCTAACTCATCGTTACCA-3') for two-LTR (2LTR) circles. Additional primers (5'-CCTCCCCCTCTTAACCAAAAC-3' and 5'-TGCTATTTCATCTTTCCCTTGC-3') were designed for the detection of mitochondrial DNA in the infected cell extracts. FAM/TAMRA (6-carboxyfluorescein/6-carboxytetramethylrhodamine) dual-labeled probes (Sigma-Genosys) specific for the RSV LTR (5'-CCATCAACCCAGGTGCACACCAATG-3') or chicken mitochondrial DNA (5'-CAGTATAGGCGATAGAAAAGACTACCCCGGC-3') were used for the quantitative-PCR (Q-PCR) reaction using a QuantiTect Probe PCR kit (QIAGEN). The viral DNA products detected in each sample were adjusted for the total input DNA, as monitored by the chicken mitochondrial DNA, to account for variations in DNA recovery during extraction. Quantitative RT-PCR of isolated viral RNA was performed using the primer pair A and D, the RSV LTR dual-labeled probe, and a QuantiTect Probe RT-PCR kit (QIAGEN).

Isolation of revertants. Cell-free medium from cells stably infected with wild-type RS.V8.eGFP or its K244R or E246A mutant was placed onto uninfected DF-1 cells. Cells were passed for one to several weeks before the medium was collected and transferred onto fresh, uninfected DF-1 cells. The transfer was repeated 12 times to allow ample opportunity for virus evolution. At various points, the culture medium was tested for the presence of infectious virus by monitoring the appearance of RT activity in the medium after transfer to uninfected cells. After 12 transfers, virions were collected, and viral RNA was isolated as above and amplified in ~1.4-kb segments using SuperScript III enzyme (Invitrogen) for RT-PCR. DNA products spanning the 5' LTR through env were then sequenced with the same primers used for amplification.


arrow
RESULTS AND DISCUSSION
 
The IKTE sequence resembles the accepted consensus Ubc9 binding and sumoylation site, {Psi}KX(E/D), in which is a hydrophobic residue and X is any residue (3, 23, 45). In the K244R mutant (Fig. 1A) substitution of an arginine for the lysine is predicted to block Ubc9 binding and eliminate this lysine as a potential site for SUMO addition (50). The replication deficiency of the K244R mutant may be due to the failure of a Ubc9-mediated event (such as sumoylation) that is important for normal infectivity or, alternatively, to structural perturbation of the CA protein or its Gag precursor that compromises the integrity of either immature or mature virus particles. In an attempt to distinguish between these possibilities, a more detailed genetic analysis of this region of CA and an examination of the nature of the replication block in the K244R mutant were undertaken. If the primary role of the 243IKTE246 sequence is to serve as a Ubc9 binding and sumoylation site, then replacement of the threonine with another amino acid or change of the glutamate to aspartate should have little effect on replication (3, 45). In contrast, replacement of the glutamate with an alanine would be expected to have a detrimental effect on RSV replication resembling the K244R mutation (50). To test these predictions, T245I, E246D, and E246A substitutions were engineered into the proviral plasmid pRS.V8.eGFP (9).


Figure 1
View larger version (28K):
[in this window]
[in a new window]

 
FIG. 1. Mutation of the IKTE sequence in RSV CA. (A) Location of the ß-hairpin mutations K244R and E246A and their corresponding suppressors in RSV Gag and CA. The mutant names reflect the Gag amino acid numbering. Arrows connect K244R and E246A to their respective suppressors. SP, spacer peptide. (B) Budding activity of the mutant Gag proteins expressed relative to the wild type. The graph represents the results of four independent experiments. (C) The spreading of GFP-marked viruses in cultures of DF-1 cells. Shown are the results of one typical experiment of three performed. (D) The specific infectivity of the K244R mutant measured by focus formation in primary turkey cells and expressed relative to the wild-type virus. The graph shows the average of three independent experiments.

Virus release and infectivity. Upon expression of each of the three new mutants in quail (QT6) cells, all appeared entirely wild type in particle release (Fig. 1B), as did the previously described K244R mutant (50). To analyze infectivity, wild-type and mutant particles were harvested from transfected QT6 cells, and equal doses were transferred to fresh cultures of chicken DF-1 cells (8, 50) that were then analyzed over time for GFP expression. The growth curve for the E246D mutant was indistinguishable from the wild-type parent with a half-time of spreading of about 8 to 9 days. The E246A mutant resembled K244R with a half-time of spreading almost three times that of the wild type (Fig. 1C). T245I had an intermediate effect with a half-time of spreading about twice that of the wild type. The same relative effects were seen when the infecting dose of each virus was increased 20-fold (data not shown). These data demonstrate the importance of these amino acids for efficient replication of the virus and are consistent with the possible involvement of Ubc9 and SUMO-1 in virus infectivity.

The magnitude of the defect in specific infectivity caused by K244R was measured in primary turkey embryo fibroblasts by a focus formation assay (5, 25) which approximates a single-cycle infectivity assay. In cultures infected with wild-type JD100 virions, small src-transformed foci were first observable at about 7 days postinfection, whereas detection of foci required another 3 to 5 days for the K244R mutant (data not shown). By day 16, when foci on all plates were fully formed, K244R mutant-infected cells yielded twofold fewer foci than those infected with wild-type virus (Fig. 1D), indicating a moderate specific infectivity defect of about twofold. Thus, the loss of infectivity in the RSV ß-hairpin mutations resemble the mild (2- to 10-fold) diminishment of infectivity observed in alanine substitutions in the ß-hairpin of HIV CA (59). A study to identify the basis for the reduced infectivity of the RSV mutants was initiated.

Nuclear trafficking of the K244R mutant Gag. RSV Gag has been shown to enter the nucleus during the process of assembly, and two Gag mutations that interfere with this pathway have dramatic replication defects (9, 47). Since sumoylation is known to regulate nuclear localization of certain proteins (23, 49), the possibility that the K244R mutation interferes with the ability of Gag to enter the nucleus was examined. QT6 cells expressing a wild-type Gag-GFP fusion protein (8) or its K244R derivative were treated prior to examination by confocal microscopy with 10 µg/ml leptomycin B, which specifically inhibits CRM1-mediated nuclear export and allows wild-type Gag to accumulate in the nucleus. Under these conditions, the K244R mutant Gag also accumulated in the nucleus, whereas in untreated control cells both wild-type and mutant proteins were seen in the cytoplasm and at the plasma membrane (data not shown). Thus, there is no evidence that the IKTE motif is required for nuclear import of the Gag protein prior to budding.

Characterization of K244R virions. Proteolytic processing of Gag in wild-type particles and the four mutants was examined by radioimmunoprecipitation of Gag-derived proteins (7, 12). The processing patterns for all the mutants proved to be similar to wild type (Fig. 2A). No unusual cleavage intermediates were detected. In particular, the cluster of CA bands (the two mature species of 237 and 240 residues and the CA-spacer peptide cleavage intermediate) that is normally detected in wild-type virus under these labeling conditions (11, 42) was unaffected by the mutations, indicating that the substitutions did not perturb the nearby N-terminal p10-CA cleavage site or the distal C-terminal cleavage sites.


Figure 2
View larger version (51K):
[in this window]
[in a new window]

 
FIG. 2. Characterization of mutant virions. (A) Analysis of Gag proteins and cleavage products in cell lysates and medium fractions of QT6 cells expressing wild-type and mutant proviral genomes. Proteins were radiolabeled, immunoprecipitated, and separated by SDS-PAGE as for the budding assays (Materials and Methods). (B) Morphology of wild-type and K244R mutant virus produced by QT6 cells examined by transmission electron microscopy (magnification, x37,000; bar, 100 nm). (C) The stability of wild-type and mutant particle cores evaluated by comparison of the CA protein recovered in the detergent-soluble and particulate fractions after exposure to nonionic detergent. For each treatment condition, CA was immunoprecipitated, separated by SDS-PAGE, and quantified by phosphorimage analysis; the CA protein in each fraction was expressed as a percentage of the total. The graph shows the average of three independent experiments. Supe, supernatant.

To examine virion size and core morphology, DF-1 cells stably infected with the wild-type virus or the K244R mutant were embedded, stained, thin-sectioned, and analyzed by EM. K244R particles were of normal size and morphology with a condensed ribonucleoprotein complex clearly visible (Fig. 2B). As is often the case with EM studies of RSV, the capsid shell could not be visualized in either the wild-type or mutant particles.

The stability of the wild-type and mutant cores was evaluated by pelleting virions through sucrose step gradients in the presence or absence of 1% Triton X-100. Between 25 and 40% of wild-type CA is reproducibly found in the pellet in a form believed to represent intact or partially disassembled cores (5, 7). Many CA mutations cause increased instability of cores, as detected by this assay (5, 7, 11, 12); however, the K244R mutant showed only a very slight and statistically insignificant (P = 0.35) decrease in the amount of detergent-resistant CA compared to the wild-type parent (Fig. 2C). Thus, the K244R substitution had no demonstrable effect on Gag processing, core morphology, particle size, or core sensitivity to detergent.

Pol, Env, and viral RNA incorporation. To evaluate whether or not K244R virions possess a normal complement of RT, the CA protein detectable in suspensions of WT and mutant particles was compared to the amount of RT enzymatic activity. Unlike the case of certain HIV CA mutations previously described (54), no obvious effect of the K244R mutation on the CA:RT ratio could be seen, indicating that the incorporation of the Pol protein and its activation by PR processing to form active RT are normal (data not shown). Similarly, the abundance of Env glycoprotein, determined by Western blotting of standardized preparations of unlabeled particles, was indistinguishable between wild-type and mutant (data not shown), as was the yield of genomic RNA analyzed by quantitative RT-PCR (Fig. 3A). Thus, the limited replication capacity of the K244R mutant could not be linked to any clear defect in incorporation of essential virion components.


Figure 3
View larger version (24K):
[in this window]
[in a new window]

 
FIG. 3. Analysis of viral nucleic acids. (A) Viral RNA extracted from standardized preparations of wild-type and mutant virions and measured by quantitative RT-PCR. Duplicate analyses were performed for each RNA sample, and the mutant RNA levels were expressed relative to the wild-type. The average of three independent experiments is displayed. (B) Viral DNA products extracted from wild-type and K244R virus-infected DF-1 cells and analyzed by quantitative PCR for the presence of minus-strand strong-stop, first-strand transfer, second-strand transfer, and 2LTR circle DNA products. The average of five independent experiments is shown. (C) Capacity of extracellular virions to synthesize viral DNA in an ERT reaction. The DNA products were extracted from virions and analyzed by Q-PCR. The data from five independent experiments were averaged.

Analysis of viral DNA products. The reverse transcription capabilities of wild-type and K244R virions were compared through the use of Q-PCR to detect DNA synthesis intermediates in the cytosol of infected DF-1 cells (Fig. 3B). The abundance of minus-strand strong-stop DNA, which marks the completion of the first 101 nucleotides of viral DNA, was decreased by ~45% in K244R virus-infected cells compared to wild type. Thus, the mutation affects synthesis at a very early stage, well before the point that entry of the reverse transcribing complexes into the nucleus is thought to occur (6, 56). First-strand transfer and second-strand transfer products were reduced by ~25 to 35% compared to the wild type, indicating no further blocks to synthesis at these stages.

The presence of circularized 2LTR circles, considered a hallmark of nuclear entry of the viral DNA (6, 56), was decreased by ~65% relative to the wild type when analyzed at 14 h postinfection (Fig. 3B). This represents a slightly more severe defect than seen with the early DNA products. Taken together with the slower development of transformation in the focus assay (see above), this could be an indication that either completion of the second strand of viral DNA or the entry of the DNA products into the nucleus is slowed by the K244R mutation. Regardless, the final yield of transformed foci exactly mirrored the twofold deficit in the earliest (e.g., the negative-strand strong-stop) DNA product, arguing that most particles that are able to complete the initial phase of genome replication will eventually succeed in infecting the cell. Thus, we conclude that the K244 residue is not critical for the final (nuclear) stages of genome replication.

A defect in DNA synthesis could also be detected in extracellular particles by the ERT assay (Fig. 3C). The ability of virions of the K244R mutant to synthesize both minus-strand strong-stop and first-strand transfer DNAs was reduced by ~50% relative to the wild-type (Fig. 3C) in spite of normal RT and genomic RNA content (Fig. 3A). This effect is consistent with the reverse transcription defect in infected cells (Fig. 3B) and with the twofold reduction in specific infectivity (Fig. 1D). Thus, the reverse transcription defect is not caused by exposure to the intracellular environment early in infection; rather, this argues that the quality of the reverse transcription complexes in the extracellular virions is compromised by the K244R mutation, likely due to a subtle structural perturbation.

Isolation of second-site suppressors. The delayed-growth phenotype of the K244R and E246A viruses was sufficient to allow the selection of revertant viruses with improved replication capacity by serially transferring virus onto fresh uninfected cells. After six such transfers of the E246A virus, the culture supernatant contained virus that was virtually identical to the wild-type in its rate of spread, while the selected K244R virus had improved only slightly compared to unpassaged K244R virus (data not shown). By transfer 12, both the selected K244R and selected E246A viruses were replicating at the wild-type level (data not shown). The original E246A and K244R mutations were detected in the respective cultures by RT-PCR amplification of the viral genome from the released particles and sequencing of the DNA products. New second-site mutations in the CA sequence were also identified in each culture. The selected E246A virus contained a single new substitution in CA (N343D, caused by an A-to-G substitution at nucleotide 1407) which results in a change from asparagine to aspartate in the NTD (Fig. 1A and 4A). Two new CA mutations were found in the RNA from the selected K244R population after 12 transfers: R325C (a C-to-T change at nucleotide 1353), which causes an arginine to cysteine change in the NTD, and C431R (a T-to-C change at nucleotide 1671), which alters the CTD with a cysteine to arginine substitution. Only the R325C substitution was detectable after only six transfers. In none of the cultures were any further nucleotide changes detected elsewhere in gag or in any other region of the genome.


Figure 4
View larger version (50K):
[in this window]
[in a new window]

 
FIG. 4. Second-site suppressors of ß-hairpin mutations. (A) Long-range interactions between ß-hairpin residues and distant residues in the N- and C-terminal CA domains. Ribbon diagrams of the NTD and CTD were created using Protein Data Bank files 1EM9 and 1EOQ. The flexible interdomain linker is illustrated by the dashed line. The K244 and E246 residues in the ß-hairpin are connected by arrows to the genetically interacting residues in the NTD and CTD. The amino acid change(s) resulting from each mutation is indicated at bottom. (B) Suppression of the E246A ß-hairpin mutation by the second-site N343D substitution in the NTD. (C) The effects of the R325C and C431R mutations and the R325C/C431R double mutation on infectivity of a virus bearing the wild-type ß-hairpin sequence. (D) Suppression of the growth deficit due to the K244R ß-hairpin substitution by the R325C/C431R (RC/CR) interdomain combination mutation. For each graph in panels B, C, and D, one representative graph from three replicate experiments is shown.

The suppression activity of the N343D, R325C, and C431R substitutions was tested by recreating them in the pRS.V8.eGFP proviral plasmid with and without the original ß-hairpin mutations. The three new mutations individually had no adverse effect on the ability of the virus to assemble and release virus particles from DF-1 cells (data not shown). When viruses bearing single and double mutations were evaluated for infectivity, the N343D substitution alone had no significant impact (Fig. 4B), consistent with the fact that this substitution is a naturally occurring polymorphism in certain strains of RSV (16). Combined with E246A, however, the N343D substitution was able to restore the infectivity of the E246A mutant to fully wild-type levels (Fig. 4B).

The R325C and C431R substitutions each had a mild detrimental effect on the growth of virus that was otherwise wild type, and these effects were additive in the R325C/C431R double mutant (Fig. 4C). Nevertheless, the combination R325C/C431R was able to strongly suppress the K244R phenotype in the triple mutant, although neither substitution alone could do this (Fig. 4D). In the converse comparison, the K244R substitution was also able to improve the growth of the R325C/C431R double mutant; the half-time of spreading for the triple mutant was 6 days versus 9 days for the double mutant (Fig. 4D). Thus, these three substitutions, although positioned far apart from one another on the CA structural model (Fig. 4A), are mutually adaptive.

Finally, suppression was found to be allele specific in that the N343D substitution had no ability to suppress the K244R mutation, nor could R325C/C431R improve the growth of the E246A ß-hairpin mutation (data not shown).

A role for Ubc9 and SUMO? Characterization of the K244R mutant has demonstrated no clear link between the IKTE Ubc9 consensus binding site and events of replication known to involve the nucleus, where many activities of SUMO-1 are known to occur. The phenotype of the K244R mutation is distinctly different from the CA sumoylation mutants of MLV that are blocked after DNA synthesis (65). Furthermore, the genetic suppressors of the K244R and E246A mutations compensated for the growth defects caused by the original mutations without either restoring a sumoylation consensus site at the original location or creating one elsewhere in CA or Gag. Thus, near-normal growth can occur independently of any Ubc9 and/or SUMO activity mediated by the IKTE motif, given changes to the amino acid sequence at distant regions of CA. Efforts to detect Ubc9 binding to RSV Gag were inconclusive (data not shown). We must conclude that, while it remains a possibility that IKTE is recognized by Ubc9 and perhaps even modified by SUMO addition, any influence on the replicative capacity of the virus is likely to be indirect due to influences on CA structure.

Structural implications. The appearance of the second-site suppressors at sites scattered across the CA protein argues that the original ß-hairpin mutations likely modulate virus infectivity by acting upon protein structure and perturbing normal assembly. The IKTE sequence lies within a region that not only contributes to intermolecular interactions between Gag molecules in immature particles and between CA monomers in mature cores but also undergoes dramatic refolding during the maturation process. Alterations of the hairpin residues, therefore, could conceivably compromise replication by affecting Gag-Gag interactions, refolding of the first 14 residues to make the ß-hairpin, the formation of CA-CA interactions in the assembled capsid, or some combination of these.

In wild-type RSV Gag, T245 appears to be involved directly in the Gag-Gag interface, while the K244 and E246 residues point away from the intermolecular interface and into the aqueous environment (39). In the mature CA, all four residues of the IKTE are surface exposed at the top of the hairpin and not apparently involved directly in CA-CA interactions (28). Direct contact between the IKTE residues and those altered by the suppressor mutations appears impossible, given the existing structural models for CA monomers, NTD hexamers, and larger arrays of assembled CAs (10, 20, 21, 28, 31, 35, 62). Therefore, it is likely that suppression occurs by a more indirect means such as influencing protein folding/conformation or protein interfaces distant from the hairpin residues. The surface location of the suppressors leads us to favor the latter possibility.

In the allele specificity experiment, failure of the N343D substitution to suppress the K244R growth defect and of the R325C/C431R combination to do the same for the E246A substitution indicates that the structural consequences of the K244R and E246A mutations are unique. It is not possible to correct both detrimental mutations with the same global strengthening mechanism. This is at least consistent with existing structural information. The N343D suppressor maps to the small helix 5 (Fig. 4A, on the "top" of the CA monomer) that is not directly involved in mature CA-CA interactions (29, 30, 39, 62) but which has been suggested to be part of the extended Gag-Gag interface in the immature RSV particle (39). On the other hand, the R325C and C431R substitutions (joint suppressors of K244R) alter helices 4 and 9, respectively, which are known to participate in the NTD-CTD and CTD-CTD interactions that form during HIV maturation (29, 30, 62). This raises the possibility that the E246A substitution alters Gag-Gag interactions, leading to secondary effects on cores upon maturation, while the K244R substitution primarily affects interactions within mature CA assemblies.

Other less dramatic examples of long-range interactions have been described within the CTD (34) and within the NTD of HIV CA (54). Also, in a previous study, RSV mutations in the highly conserved major homology region of the CA CTD (5) were found to be compensated in revertant viruses by secondary changes in either an adjacent {alpha}-helix or by an interdomain interaction with surface residues in the NTD. The K244R mutation and its two cooperating suppressors, however, provide a particularly powerful demonstration of the importance of long-range structural influences in forming a functional virion core. Unfortunately, the lack of high-resolution structural models for either assembled immature particles or mature capsids of any retrovirus limits our ability to explain more fully the long-range structural effects of the mutations. All these mutations, however, will ultimately serve as important tests of validity as more complete models of the immature and mature assemblies are developed.

Finally, the lethal major homology region mutations previously described in RSV (7) and the ß-hairpin substitutions presented here, as well as others characterized in HIV and MLV (1, 17, 18, 54, 55), are similar in their effects on replication: all affect the capacity of the viral core to carry out an early step of viral DNA synthesis. Taken altogether these findings demonstrate that some structural feature of the capsid, which remains unidentified, is critical for either the formation or the function of reverse transcription complex.


arrow
ACKNOWLEDGMENTS
 
Thanks are due to Judith M. White for the anti-TM antibody, BoYeon Choi Kimmel and Tam-Linh Nguyen for technical assistance on mutant characterization, Ira Ropson for consultation on protein structure, and John Purdy for careful review of the manuscript. Several procedures were performed in the Pennsylvania State University College of Medicine Core Facilities, where Roland Meyers (EM), Terry Ruger and Dan Krissinger (Q-PCR), and Nate Sheaffer (fluorescence-activated cell sorting) provided essential expertise.

This work was supported by National Institutes of Health grants CA47482 to J.W.W. and CA100322 to R.C.C.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Department of Microbiology and Immunology, Pennsylvania State University College of Medicine, 500 University Drive, Hershey, PA 17033. Phone: (717) 531-3528. Fax: (717) 531-6522. E-mail: rcraven{at}psu.edu. Back

{triangledown} Published ahead of print on 8 November 2006. Back

{dagger} Present address: Centocor R&D, Inc., 145 King of Prussia Rd., Radnor, PA 19087. Back


arrow
REFERENCES
 
    1
  1. Alin, K., and S. P. Goff. 1996. Amino acid substitutions in the CA protein of Moloney murine leukemia virus that block early events in infection. Virology 222:339-351.[CrossRef][Medline]
  2. 2
  3. Barklis, E., J. McDermott, S. Wilkens, S. Fuller, and D. Thompson. 1998. Organization of HIV-1 capsid proteins on a lipid monolayer. J. Biol. Chem. 273:7177-7180.[Abstract/Free Full Text]
  4. 3
  5. Bernier-Villamor, V., D. A. Sampson, M. J. Matunis, and C. D. Lima. 2002. Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1. Cell 108:345-356.[CrossRef][Medline]
  6. 4
  7. Bowerman, B., P. O. Brown, J. M. Bishop, and H. E. Varmus. 1989. A nucleoprotein complex mediates the integration of retroviral DNA. Genes Dev. 3:469-478.[Abstract/Free Full Text]
  8. 5
  9. Bowzard, J. B., J. W. Wills, and R. C. Craven. 2001. Second-site suppressors of Rous sarcoma virus CA mutations: evidence for interdomain interactions. J. Virol. 75:6850-6856.[Abstract/Free Full Text]
  10. 6
  11. Brown, P. O. 1997. Integration, p. 161-204. In J. M. Coffin, S. H. Hughes, and H. Varmus (ed.), Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
  12. 7
  13. Cairns, T. M., and R. C. Craven. 2001. Viral DNA synthesis defects in assembly competent Rous sarcoma virus CA mutants. J. Virol. 75:242-250.[Abstract/Free Full Text]
  14. 8
  15. Callahan, E. M., and J. W. Wills. 2000. Repositioning basic residues in the M domain of the Rous sarcoma virus Gag protein. J. Virol. 74:11222-11229.[Abstract/Free Full Text]
  16. 9
  17. Callahan, E. M., and J. W. Wills. 2003. Link between genome packaging and rate of budding for Rous sarcoma virus. J. Virol. 77:9388-9398.[Abstract/Free Full Text]
  18. 10
  19. Campos-Olivas, R., J. L. Newman, and M. F. Summers. 2000. Solution structure and dynamics of the Rous sarcoma virus capsid protein and comparison with capsid proteins of other retroviruses. J. Mol. Biol. 296:633-649.[CrossRef][Medline]
  20. 11
  21. Craven, R. C., A. E. Leure-duPree, C. R. Erdie, C. B. Wilson, and J. W. Wills. 1993. Necessity of the spacer peptide between CA and NC in the Rous sarcoma virus Gag protein. J. Virol. 67:6246-6252.[Abstract/Free Full Text]
  22. 12
  23. Craven, R. C., A. E. Leure-duPree, R. A. Weldon, and J. W. Wills. 1995. Genetic analysis of the major homology region of the Rous sarcoma virus Gag protein. J. Virol. 69:4213-4227.[Abstract]
  24. 13
  25. Dorfman, T., A. Bukovsky, A. Ohagen, S. Hoglund, and H. G. Gottlinger. 1994. Functional domains of the capsid protein of human immunodeficiency virus type 1. J. Virol. 68:8180-8187.[Abstract/Free Full Text]
  26. 14
  27. Fassati, A., and S. P. Goff. 1999. Characterization of intracellular reverse transcription complexes of Moloney murine leukemia virus. J. Virol. 73:8919-8925.[Abstract/Free Full Text]
  28. 15
  29. Fassati, A., and S. P. Goff. 2001. Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1. J. Virol. 75:3626-3635.[Abstract/Free Full Text]
  30. 16
  31. Federspiel, M. J., and S. H. Hughes. 1994. Effects of the gag region on genome stability: avian retroviral vectors that contain sequences from the Bryan strain of Rous sarcoma virus. Virology 203:211-220.[CrossRef][Medline]
  32. 17
  33. Fitzon, T., B. Leschonsky, K. Bieler, C. Paulus, J. Schroder, H. Wolf, and R. Wagner. 2000. Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication. Virology 268:294-307.[CrossRef][Medline]
  34. 18
  35. Forshey, B. M., U. von Schwedler, W. I. Sundquist, and C. Aiken. 2002. Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication. J. Virol. 76:5667-5677.[Abstract/Free Full Text]
  36. 19
  37. Fuller, S. D., T. Wilk, B. E. Gowen, H. G. Krausslich, and V. M. Vogt. 1997. Cryo-electron microscopy reveals ordered domains in the immature HIV-1 particle. Curr. Biol. 7:729-738.[CrossRef][Medline]
  38. 20
  39. Ganser, B. K., A. Cheng, W. I. Sundquist, and M. Yeager. 2003. Three-dimensional structure of the M-MuLV CA protein on a lipid monolayer: a general model for retroviral capsid assembly. EMBO J. 22:2886-2892.[CrossRef][Medline]
  40. 21
  41. Gitti, R. K., B. M. Lee, J. Walker, M. F. Summers, S. Yoo, and W. I. Sunquist. 1996. Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science 273:231-235.[Abstract]
  42. 22
  43. Hatziioannou, T., S. Cowan, U. K. von Schwedler, W. I. Sundquist, and P. D. Bieniasz. 2004. Species-specific tropism determinants in the human immunodeficiency virus type 1 capsid. J. Virol. 78:6005-6012.[Abstract/Free Full Text]
  44. 23
  45. Hilgarth, R. S., L. A. Murphy, H. S. Skaggs, D. C. Wilkerson, H. Xing, and K. D. Sarge. 2004. Regulation and function of SUMO modification. J. Biol. Chem. 279:53899-53902.[Free Full Text]
  46. 24
  47. Hirt, B. 1967. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26:365-3369.[CrossRef][Medline]
  48. 25
  49. Hunter, E. 1979. Biological techniques for avian sarcoma viruses, p. 379-393. In W. B. Jakoby and I. H. Pastan (ed.), Methods in enzymology, vol. 58. Academic Press, Inc., New York, NY.[Medline]
  50. 26
  51. Katz, R. A., J. H. Omer, J. H. Weis, S. A. Mitsialis, A. J. Fara, and R. V. Guntaka. 1982. Restriction endonuclease and nucleotide sequence analysis of molecularly cloned unintegrated avian tumor virus DNA: structure of large terminal repeats in circle junctions. J. Virol. 42:346-351.[Abstract/Free Full Text]
  52. 27
  53. Kaukinen, P., A. Vaheri, and A. Plyusnin. 2003. Non-covalent interaction between nucleocapsid protein of Tula hantavirus and small ubiquitin-related modifier-1, SUMO-1. Virus Res. 92:37-45.[CrossRef][Medline]
  54. 28
  55. Kingston, R. L., T. Fitzon-Ostendorp, E. Z. Eisenmesser, G. W. Schatz, V. M. Vogt, C. B. Post, and M. G. Rossmann. 2000. Structure and self-association of the Rous sarcoma virus capsid protein. Struct. Fold Des. 8:617-628.[Medline]
  56. 29
  57. Lanman, J., T. T. Lam, S. Barnes, M. Sakalian, M. R. Emmett, A. G. Marshall, and P. E. Prevelige, Jr. 2003. Identification of novel interactions in HIV-1 capsid protein assembly by high-resolution mass spectrometry. J. Mol. Biol. 325:759-772.[CrossRef][Medline]
  58. 30
  59. Lanman, J., T. T. Lam, M. R. Emmett, A. G. Marshall, M. Sakalian, and P. E. Prevelige, Jr. 2004. Key interactions in HIV-1 maturation identified by hydrogen-deuterium exchange. Nat. Struct. Mol. Biol. 11:676-677.[CrossRef][Medline]
  60. 31
  61. Li, S., C. P. Hill, W. I. Sundquist, and J. T. Finch. 2000. Image reconstructions of helical assemblies of the HIV-1 CA protein. Nature 407:409-413.[CrossRef][Medline]
  62. 32
  63. Maeda, A., B. H. Lee, K. Yoshimatsu, M. Saijo, I. Kurane, J. Arikawa, and S. Morikawa. 2003. The intracellular association of the nucleocapsid protein (NP) of Hantaan virus (HTNV) with small ubiquitin-like modifier-1 (SUMO-1) conjugating enzyme 9 (Ubc9). Virology 305:288-297.[CrossRef][Medline]
  64. 33
  65. Mammano, F., A. Ohagen, S. Hoglund, and H. G. Gottlinger. 1994. Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis. J. Virol. 68:4927-4936.[Abstract/Free Full Text]
  66. 34
  67. Mateu, M. G. 2002. Conformational stability of dimeric and monomeric forms of the C-terminal domain of human immunodeficiency virus-1 capsid protein. J. Mol. Biol. 318:519-531.[CrossRef][Medline]
  68. 35
  69. Mayo, K., M. L. Vana, J. McDermott, D. Huseby, J. Leis, and E. Barklis. 2002. Analysis of Rous sarcoma virus capsid protein variants assembled on lipid monolayers. J. Mol. Biol. 316:667-678.[CrossRef][Medline]
  70. 36
  71. McDonald, D., M. A. Vodicka, G. Lucero, T. M. Svitkina, G. G. Borisy, M. Emerman, and T. J. Hope. 2002. Visualization of the intracellular behavior of HIV in living cells. J. Cell Biol. 159:441-452.[Abstract/Free Full Text]
  72. 37
  73. Mortuza, G. B., L. F. Haire, A. Stevens, S. J. Smerdon, J. P. Stoye, and I. A. Taylor. 2004. High-resolution structure of a retroviral capsid hexameric amino-terminal domain. Nature 431:481-485.[CrossRef][Medline]
  74. 38
  75. Moscovici, C., M. G. Moscovici, H. Jimenez, M. M. C. Lai, M. J. Hayman, and P. K. Vogt. 1977. Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail. Cell 11:95-103.[CrossRef][Medline]
  76. 39
  77. Nandhagopal, N., A. A. Simpson, M. C. Johnson, A. B. Francisco, G. W. Schatz, M. G. Rossmann, and V. M. Vogt. 2004. Dimeric Rous sarcoma virus capsid protein structure relevant to immature Gag assembly. J. Mol. Biol. 335:275-282.[CrossRef][Medline]
  78. 40
  79. Owens, C. M., B. Song, M. J. Perron, P. C. Yang, M. Stremlau, and J. Sodroski. 2004. Binding and susceptibility to postentry restriction factors in monkey cells are specified by distinct regions of the human immunodeficiency virus type 1 capsid. J. Virol. 78:5423-5437.[Abstract/Free Full Text]
  80. 41
  81. Parent, L. J., T. M. Cairns, J. A. Albert, C. B. Wilson, J. W. Wills, and R. C. Craven. 2000. RNA dimerization defect in a Rous sarcoma virus matrix mutant. J. Virol. 74:164-172.[Abstract/Free Full Text]
  82. 42
  83. Pepinsky, R. B., I. A. Papayannopoulos, E. P. Chow, N. K. Krishna, R. C. Craven, and V. M. Vogt. 1995. Differential proteolytic processing leads to multiple forms of the CA protein in avian sarcoma and leukemia viruses. J. Virol. 69:6430-6438.[Abstract]
  84. 43
  85. Reicin, A. S., A. Ohagen, L. Yin, S. Hoglund, and S. P. Goff. 1996. The role of Gag in human immunodeficiency virus type 1 virion morphogenesis and early steps of the viral life cycle. J. Virol. 70:8645-8652.[Abstract]
  86. 44
  87. Rulli, S. J., Jr., D. Muriaux, K. Nagashima, J. Mirro, M. Oshima, J. G. Baumann, and A. Rein. 2006. Mutant murine leukemia virus Gag proteins lacking proline at the N-terminus of the capsid domain block infectivity in virions containing wild-type Gag. Virology 347:364-371.[CrossRef][Medline]
  88. 45
  89. Sampson, D. A., M. Wang, and M. J. Matunis. 2001. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification. J. Biol. Chem. 276:21664-21669.[Abstract/Free Full Text]
  90. 46
  91. Schaefer-Klein, J., I. Givol, E. V. Barsov, J. M. Whitcomb, M. VanBrocklin, D. N. Foster, M. J. Federspiel, and S. H. Hughes. 1998. The EV-O-derived cell line DF-1 supports the efficient replication of avian leukosis-sarcoma viruses and vectors. Virology 248:305-311.[CrossRef][Medline]
  92. 47
  93. Scheifele, L. Z., R. A. Garbitt, J. D. Rhoads, and L. J. Parent. 2002. Nuclear entry and CRM1-dependent nuclear export of the Rous sarcoma virus Gag polyprotein. Proc. Natl. Acad. Sci. USA 99:3944-3949.[Abstract/Free Full Text]
  94. 48
  95. Schwartz, D. E., R. Tizard, and W. Gilbert. 1983. Nucleotide sequence of Rous sarcoma virus. Cell 32:853-869.[CrossRef][Medline]
  96. 49
  97. Seeler, J. S., and A. Dejean. 2003. Nuclear and unclear functions of SUMO. Nat. Rev. Mol. Cell Biol. 4:690-699.[CrossRef][Medline]
  98. 50
  99. Spidel, J. L., R. C. Craven, C. B. Wilson, A. Patnaik, H. Wang, L. M. Mansky, and J. W. Wills. 2004. Lysines close to the Rous sarcoma virus late domain critical for budding. J. Virol. 78:10606-10616.[Abstract/Free Full Text]
  100. 51
  101. Stevens, A., M. Bock, S. Ellis, P. LeTissier, K. N. Bishop, M. W. Yap, W. Taylor, and J. P. Stoye. 2004. Retroviral capsid determinants of Fv1 NB and NR tropism. J. Virol. 78:9592-9598.[Abstract/Free Full Text]
  102. 52
  103. Strambio-de-Castillia, C., and E. Hunter. 1992. Mutational analysis of the major homology region of Mason-Pfizer monkey virus by use of saturation mutagenesis. J. Virol. 66:7021-7032.[Abstract/Free Full Text]
  104. 53
  105. Tang, C., Y. Ndassa, and M. F. Summers. 2002. Structure of the N-terminal 283-residue fragment of the immature HIV-1 Gag polyprotein. Nat. Struct. Biol. 9:537-543.[Medline]
  106. 54
  107. Tang, S., T. Murakami, N. Cheng, A. C. Steven, E. O. Freed, and J. G. Levin. 2003. Human immunodeficiency virus type 1 N-terminal capsid mutants containing cores with abnormally high levels of capsid protein and virtually no reverse transcriptase. J. Virol. 77:12592-12602.[Abstract/Free Full Text]
  108. 55
  109. Tang, S., T. Murakami, B. E. Agresta, S. Campbell, E. O. Freed, and J. G. Levin. 2001. Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells. J. Virol. 75:9357-9366.[Abstract/Free Full Text]
  110. 56
  111. Telesnitsky, A., and S. P. Goff. 1997. Reverse transcriptase and the generation of retroviral DNA, p. 121-160. In J. M. Coffin, S. H. Hughes, and H. Varmus (ed.), Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
  112. 57
  113. Towers, G., M. Bock, S. Martin, Y. Takeuchi, J. P. Stoye, and O. Danos. 2000. A conserved mechanism of retrovirus restriction in mammals. Proc. Natl. Acad. Sci. USA 97:12295-12299.[Abstract/Free Full Text]
  114. 58
  115. von Schwedler, U. K., T. L. Stemmler, V. Y. Klishko, S. Li, K. H. Albertine, D. R. Davis, and W. I. Sundquist. 1998. Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly. EMBO J. 17:1555-1568.[CrossRef][Medline]
  116. 59
  117. von Schwedler, U. K., K. M. Stray, J. E. Garrus, and W. I. Sundquist. 2003. Functional surfaces of the human immunodeficiency virus type 1 capsid protein. J. Virol. 77:5439-5450.[Abstract/Free Full Text]
  118. 60
  119. Wang, C. T., and E. Barklis. 1993. Assembly, processing, and infectivity of human immunodeficiency virus type 1 Gag mutants. J. Virol. 67:4264-4273.[Abstract/Free Full Text]
  120. 61
  121. Weldon, R. A., Jr., P. Sarkar, S. M. Brown, and S. K. Weldon. 2003. Mason-Pfizer monkey virus Gag proteins interact with the human sumo conjugating enzyme, hUbc9. Virology 314:62-73.[CrossRef][Medline]
  122. 62
  123. Worthylake, D. K., H. Wang, S. Yoo, W. I. Sundquist, and C. P. Hill. 1999. Structures of the HIV-1 capsid protein dimerization domain at 2.6 Å resolution. Acta Crystallogr. D 55:85-92.[CrossRef][Medline]
  124. 63
  125. Yeager, M., E. M. Wilson-Kubalek, S. G. Wiener, P. O. Brown, and A. Rein. 1998. Supramolecular organization of immature and mature murine leukemia virus revealed by electron cryo-microscopy: implications for retroviral assembly mechanisms. Proc. Natl. Acad. Sci. USA 95:7299-7304.[Abstract/Free Full Text]
  126. 64
  127. Yu, F., S. M. Joshi, Y. M. Ma, R. L. Kingston, M. N. Simon, and V. M. Vogt. 2001. Characterization of Rous sarcoma virus Gag particles assembled in vitro. J. Virol. 75:2753-2764.[Abstract/Free Full Text]
  128. 65
  129. Yueh, A., J. Leung, S. Bhattacharyya, L. A. Perrone, S. K. de Los, S. Y. Pu, and S. P. Goff. 2006. Interaction of Moloney murine leukemia virus capsid with Ubc9 and PIASy mediates SUMO-1 addition required early in infection. J. Virol. 80:342-352.[Abstract/Free Full Text]


Journal of Virology, February 2007, p. 1288-1296, Vol. 81, No. 3
0022-538X/07/$08.00+0     doi:10.1128/JVI.01551-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Purdy, J. G., Flanagan, J. M., Ropson, I. J., Rennoll-Bankert, K. E., Craven, R. C. (2008). Critical Role of Conserved Hydrophobic Residues within the Major Homology Region in Mature Retroviral Capsid Assembly. J. Virol. 82: 5951-5961 [Abstract] [Full Text]  
  • Auerbach, M. R., Brown, K. R., Singh, I. R. (2007). Mutational Analysis of the N-Terminal Domain of Moloney Murine Leukemia Virus Capsid Protein. J. Virol. 81: 12337-12347 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spidel, J. L.
Right arrow Articles by Wills, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spidel, J. L.
Right arrow Articles by Wills, J. W.